These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 26958710)

  • 101. Benchmarking methods and data sets for ligand enrichment assessment in virtual screening.
    Xia J; Tilahun EL; Reid TE; Zhang L; Wang XS
    Methods; 2015 Jan; 71():146-57. PubMed ID: 25481478
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Can We Still Trust Docking Results? An Extension of the Applicability of DockBench on PDBbind Database.
    Bolcato G; Cuzzolin A; Bissaro M; Moro S; Sturlese M
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31330841
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Generative Models Should at Least Be Able to Design Molecules That Dock Well: A New Benchmark.
    Ciepliński T; Danel T; Podlewska S; Jastrzȩbski S
    J Chem Inf Model; 2023 Jun; 63(11):3238-3247. PubMed ID: 37224003
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Systematic Studies on the Protocol and Criteria for Selecting a Covalent Docking Tool.
    Wen C; Yan X; Gu Q; Du J; Wu D; Lu Y; Zhou H; Xu J
    Molecules; 2019 Jun; 24(11):. PubMed ID: 31185706
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Docking Screens for Novel Ligands Conferring New Biology.
    Irwin JJ; Shoichet BK
    J Med Chem; 2016 May; 59(9):4103-20. PubMed ID: 26913380
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Maximal Unbiased Benchmarking Data Sets for Human Chemokine Receptors and Comparative Analysis.
    Xia J; Reid TE; Wu S; Zhang L; Wang XS
    J Chem Inf Model; 2018 May; 58(5):1104-1120. PubMed ID: 29698608
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Improving inverse docking target identification with Z-score selection.
    Kim SS; Aprahamian ML; Lindert S
    Chem Biol Drug Des; 2019 Jun; 93(6):1105-1116. PubMed ID: 30604454
    [TBL] [Abstract][Full Text] [Related]  

  • 108. MUBD-DecoyMaker 2.0: A Python GUI Application to Generate Maximal Unbiased Benchmarking Data Sets for Virtual Drug Screening.
    Xia J; Li S; Ding Y; Wu S; Wang XS
    Mol Inform; 2020 Apr; 39(4):e1900151. PubMed ID: 31828959
    [TBL] [Abstract][Full Text] [Related]  

  • 109. In Need of Bias Control: Evaluating Chemical Data for Machine Learning in Structure-Based Virtual Screening.
    Sieg J; Flachsenberg F; Rarey M
    J Chem Inf Model; 2019 Mar; 59(3):947-961. PubMed ID: 30835112
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Decoys Selection in Benchmarking Datasets: Overview and Perspectives.
    Réau M; Langenfeld F; Zagury JF; Lagarde N; Montes M
    Front Pharmacol; 2018; 9():11. PubMed ID: 29416509
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Sodium or Not Sodium: Should Its Presence Affect the Accuracy of Pose Prediction in Docking GPCR Antagonists?
    Bassani D; Pavan M; Sturlese M; Moro S
    Pharmaceuticals (Basel); 2022 Mar; 15(3):. PubMed ID: 35337144
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Docking and chemoinformatic screens for new ligands and targets.
    Kolb P; Ferreira RS; Irwin JJ; Shoichet BK
    Curr Opin Biotechnol; 2009 Aug; 20(4):429-36. PubMed ID: 19733475
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Assessment of the Fragment Docking Program SEED.
    Goossens K; Wroblowski B; Langini C; van Vlijmen H; Caflisch A; De Winter H
    J Chem Inf Model; 2020 Oct; 60(10):4881-4893. PubMed ID: 32820916
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Special Protein Molecules Computational Identification.
    Zou Q; He W
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29439426
    [TBL] [Abstract][Full Text] [Related]  

  • 115. What in silico molecular docking can do for the 'bench-working biologists'.
    Mihăşan M
    J Biosci; 2012 Dec; 37(6):1089-95. PubMed ID: 23151798
    [TBL] [Abstract][Full Text] [Related]  

  • 116. CACHE (Critical Assessment of Computational Hit-finding Experiments): A public-private partnership benchmarking initiative to enable the development of computational methods for hit-finding.
    Ackloo S; Al-Awar R; Amaro RE; Arrowsmith CH; Azevedo H; Batey RA; Bengio Y; Betz UAK; Bologa CG; Chodera JD; Cornell WD; Dunham I; Ecker GF; Edfeldt K; Edwards AM; Gilson MK; Gordijo CR; Hessler G; Hillisch A; Hogner A; Irwin JJ; Jansen JM; Kuhn D; Leach AR; Lee AA; Lessel U; Morgan MR; Moult J; Muegge I; Oprea TI; Perry BG; Riley P; Rousseaux SAL; Saikatendu KS; Santhakumar V; Schapira M; Scholten C; Todd MH; Vedadi M; Volkamer A; Willson TM
    Nat Rev Chem; 2022 Apr; 6(4):287-295. PubMed ID: 35783295
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Virtual screen raises hit rate.
    Barranco C
    Nat Struct Mol Biol; 2022 Nov; 29(11):1037. PubMed ID: 36352141
    [No Abstract]   [Full Text] [Related]  

  • 118. A Molecular Mechanism for Sequential Activation of a G Protein-Coupled Receptor.
    Grundmann M; Tikhonova IG; Hudson BD; Smith NJ; Mohr K; Ulven T; Milligan G; Kenakin T; Kostenis E
    Cell Chem Biol; 2016 Mar; 23(3):392-403. PubMed ID: 26991104
    [TBL] [Abstract][Full Text] [Related]  

  • 119. The β-Arrestins: Multifunctional Regulators of G Protein-coupled Receptors.
    Smith JS; Rajagopal S
    J Biol Chem; 2016 Apr; 291(17):8969-77. PubMed ID: 26984408
    [TBL] [Abstract][Full Text] [Related]  

  • 120. A Hybrid Approach to Structure and Function Modeling of G Protein-Coupled Receptors.
    Latek D; Bajda M; Filipek S
    J Chem Inf Model; 2016 Apr; 56(4):630-41. PubMed ID: 26978043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.